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Abstract Hereditary spherocytosis is an inherited red blood
cell membrane disorder resulting from mutations of genes
encoding erythrocyte membrane and cytoskeletal proteins.
Few equipments can observe the structural characteristics of
hereditary spherocytosis directly expect for atomic force
microscopy In our study, we proved atomic force micro-
scopy is a powerful and sensitive instrument to describe the
characteristics of hereditary spherocytosis. Erythrocytes
from hereditary spherocytosis patients were small spher-
oidal, lacking a well-organized lattice on the cell membrane,
with smaller cell surface particles and had reduced valley to
peak distance and average cell membrane roughness vs.
those from healthy individuals. These observations indi-
cated defects in the certain cell membrane structural pro-
teins such as α- and β-spectrin, ankyrin, etc. Until now,
splenectomy is still the most effective treatment for symp-
toms relief for hereditary spherocytosis. In this study, we
further solved the mysteries of membrane nanostructure
changes of erythrocytes before and after splenectomy in
hereditary spherocytosis by atomic force microscopy. After
splenectomy, the cells were larger, but still spheroidal-
shaped. The membrane ultrastructure was disorganized and
characterized by a reduced surface particle size and lower
than normal Ra values. These observations indicated that
although splenectomy can effectively relieve the symptoms of
hereditary spherocytosis, it has little effect on correction of
cytoskeletal membrane defects of hereditary spherocytosis.
We concluded that atomic force microscopy is a powerful tool
to investigate the pathophysiological mechanisms of heredi-
tary spherocytosis and to monitor treatment efﬁcacy in clinical
practices. To the best of our knowledge, this is the ﬁrst report
to study hereditary spherocytosis with atomic force micro-
scopy and offers important mechanistic insight into the
underlying role of splenectomy.
Keywords Atomic force microscopy ● Hereditary
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Introduction
Hereditary spherocytosis (HS) is by far the most common
congenital hemolytic anemia in Northern European des-
cendants [1]. The hallmarks of the disease are anemia,
jaundice, and splenomegaly; with the age of onset of clin-
ical symptoms, their severity are relatively variable. Severe
HS patients may also have growth retardation and hemo-
lytic crises. HS is characterized by spherical red blood cells
(RBCs, or erythrocytes) in the peripheral blood rather than
the normal biconcave RACs. Recent researches has dis-
covered erythrocytes in HS are deﬁcient in certain structural
proteins including α- and β-spectrin, ankyrin, protein 4.1,
and etc [2]. Such deﬁciencies result in cytoskeleton dis-
ruption and/or reorganization. This manifests as membrane
instability that force the cells to occupy the smallest volume
possible, i.e., a sphere. Therefore, the rounded erythrocytes
(spherocytes) have impaired deformability and are more
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prone to hemolysis than normal RBCs. Moreover, spher-
ocytes are trapped during their passage through the spleenic
pulp and are selectively destroyed. Currently, there is no
cure for the genetic defects underlying HS, and splenectomy
and folic acid supplements are the most effective treatment
for chronic symptoms of anemia and moderate to severe
splenomegaly cases [3].
There are several tools to investigate the surface of RBCs.
Flow cytometry measures optical and ﬂuorescence char-
acteristics of single cells and resolves physical properties
such as size (represented by forward angle light scatter) and
internal complexity (represented by right-angle scatter) of
certain cell populations. Additionally, ﬂuorescent dyes or
antibodies conjugated to ﬂuorescent dyes may bind or
intercalate with different cellular components or bind speciﬁc
proteins on cell membranes or inside cells [4]. For example,
ﬂow cytometry has been increasingly used for the detection
and quantiﬁcation of fetal red cells in maternal blood [5–8].
Antibodies to CD55 and CD59 are speciﬁc for decay-
accelerating factor and membrane-inhibitor of reactive
hemolysis, respectively, and can be analyzed by ﬂow cyto-
metry to make a deﬁnitive diagnosis of PNH [9–11]. Reti-
culocyte counting using ﬂuorescent dyes that bind the
residual RNA such as thiazole orange provides excellent
discrimination between reticulocytes and mature RBCs with
greater precision, sensitivity, and reproducibility than the
traditional method [12, 13]. Light microscopy offers rapid
information on morphology, but the resolution is roughly
limited to half the wavelength of light. In electron micro-
scopy, nanometer-scale resolution can easily be achieved on
negatively stained samples. However, none of the three
methods can make precise structural measurements along the
z-axis, which atomic force microscopy (AFM) can facilitate.
In past several decades, AFM has become a powerful
technique for studying the mechanical properties (stiffness,
viscoelasticity, hardness, and adhesion) of various biologi-
cal materials. The unique combination of high-resolution
topography and operation under physiological environ-
ments has made it useful in many studies of cell properties
[14, 15]. Though AFM has been employed to image RBCs
in lab for over a decade [16, 17]. The changes of HS
patients are still remained unknown.
AFM uses a sharp probe (tip) mounted to the end of a
ﬂexible cantilever that deﬂects when interacting with the
cell surface. The cells can be scanned in X and Y directions
via a piezoelectric scanner. Changes in height (Z direction)
due to tip interactions with the cell surface are detected with
a laser and a position-sensitive detector (i.e. photodetector)
[14]. AFM allows quantitative measurement of the RBCs
surface mechanical properties in various disease conditions
[18–21] and chemical stimuli [22–24].
However, reorganization of the topological structures
and membrane nanostructure of RBCs after splenectomy,
especially in HS patients, has not yet been investigated and
may offer critical insight into the mechanism of action.
Here, we used AFM to probe RBC nanoscale surfaces and
compared the morphology and membrane nanostructure of
these cells before and after splenectomy. The results will
facilitate a better understanding of the impact of sple-
nectomy on RBCs from HS patients.
Materials and Methods
Participants
Three patients (one male and two female, aged 19, 23, and
27 years, respectively) diagnosed with HS in August 2013
at The First Afﬁliated Hospital, Sun Yat-Sen University
were enrolled in this study. Three healthy controls (one
male and two female, aged 20, 23, and 27 years, respec-
tively) were also included. The patients were diagnosed of
HS according to Guidelines for the diagnosis and manage-
ment of hereditary spherocytosis—2011 update [25]. All
studies were approved and conducted in accordance with
Internal Review Board of the hospital. Proper informed
consent forms were obtained from all blood donors in
accordance with the principles of the Declaration of Hel-
sinki on Biomedical Research. None of the patients had any
complications or co-morbidities. All three patients pre-
sented with anemia, jaundice and splenomegaly. They
underwent splenectomy after diagnosis with HS.
Sample Preparation
Before and 3 months after splenectomy, 2 ml of blood was
drawn from the cubital vein in the early morning—1 ml in
an EDTA tube for whole blood cell counting and classiﬁ-
cation and another 1 ml in a heparin tube, which was cen-
trifuged at ×300 g for 10 min. 2 ml of blood from healthy
controls were drawn from the cubital vein in the early
morning just as the patients. For the heparin tube, the
supernatant was discarded (plasma, platelets, and white
blood cells) and the remaining erythrocyte pellet was sus-
pended in 0.01 M phosphate buffered saline (PBS). The cell
concentration was adjusted to 1~2 × 1011 cells per liter with
a hemocytometer. Five microliter of the RBC suspension
was added to a clean, Cell-Tak adhesive treated class cov-
erslip, ﬁxed with 1 % glutaraldehyde for 15 min, and rinsed
with deionized water 2 to 3 times. The samples were then
air dried for AFM analysis.
AFM Imaging and Measurement
Topographic images of erythrocytes were obtained from
AFM (Autoprobe CP Research, Veeco) in tapping mode.
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A gold-coated silicon nitride tips (UL20B; Park Scientiﬁc
Instruments) with a spring constant of 2.5 N/m and a tip
diameter of 20 nm were used in all experiments. An optical
microscope was used to help select the desired cells and
direct the position of the AFM tip. The samples were placed
on the AFM sample stage. The location of the cell and AFM
tip were identiﬁed with light microscopy. The cells were
scanned randomly in the air using tapping mode. Five cells
from each sample were scanned, and the scans were repe-
ated for a total of three times. AFM topographic images
were processed and analyzed using XEI software (Park
Systems Corp, Korean) and a smoothing ﬁlter was applied
to remove the low frequency noise on scanning directions.
The erythrocyte width (W) and length (L) represented the
minimum and maximum diameter of red blood cells,
respectively. The term r was the L to W ratio. The value of h
and H represented the minimum and maximum height of the
cell. The valley to peak distance (Rp-v) represented the
difference between the minimal and maximal height on the
Z-axis in the area analyzed. Ra was the average cell surface
roughness.
Statistical Analysis
The RBC morphology, cell surface topological structures
and membrane nanostructure were expressed as mean ±
standard deviation (SD). All the data were analyzed using
SPSS 18.0 software (SPSS Inc.; Tokyo, Japan). The mor-
phological parameters of erythrocytes collected from heal-
thy volunteers, and HS patients before and after
splenectomy were compared using a univariate analysis of
variance method. A p value less than 0.05 was considered
statistically signiﬁcant.
Results
RBC-related Parameters from Complete Blood Count
Tests in HS Patients before and after Splenectomy
All three HS patients were anemia with decreased RBC
counts, hemoglobin level, and mean corpuscular volume
(MCV), and increased mean corpuscular hemoglobin con-
centration (MCHC), percentage of reticulocyte counts, and
red blood cell distribution width (RDW) (Table 1). All
patients had normal serum ferritin levels, and were negative
for the thalassemia gene mutation tests and were positive in
the osmotic fragility tests. All three patients had family
histories of HS and showed an increased number of
spherocytes in the peripheral blood smear (16 %, 23 %, and
20 %; Fig. 1). After HS had been diagnosed, the patients
underwent surgeries to treat HS. After surgery, the patients
Table 1 Characteristics of routine blood test of HS patients before and after splenectomy
RBC (×1012) Hb (g/L) MCV (fL) MCHC (g/L) Ret (%) RDW (%)
Pre-SE 2.45± 0.11** 72.00± 5.66** 84.55± 4.45* 348.00± 5.66** 26.67± 1.53** 22.00± 3.83**
Post-SE 4.22± 0.67 125.30± 24.90 89.47± 5.24 331.80± 31.79 1.77± 0.25** 17.33± 4.62
Control 4.36± 0.27 133.30± 9.07 91.53± 0.31 333.67± 1.15 0.67± 0.58 13.00± 1.00
RBC red blood cell count, Hb hemoglobin,MCV mean corpuscular volume,MCHC mean corpuscular hemoglobin concentration, Ret reticulocytes,
RDW red blood cell distribution width
* P< 0.05 compared to the control group; ** P< 0.01 compared to the control group
Fig. 1 Optical microscopy images of peripheral blood smears of normal control a HS before splenectomy b and HS after splenectomy c. Scale bar:
10 μm (Giemsa and Wright staining, original magniﬁcation: ×1000)
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had increased RBC, Hb, MCV values, and decreased
MCHC, percentage of reticulocyte count and RDW
(Table 1).
Representative peripheral blood smear images from
healthy controls and HS patients before splenectomy and
after splenectomy were shown in Fig. 1. The HS patients
before splenectomy had many morphologically abnormal
and small RBCs (about 6 μm in diameter). These cells
lacked a central zone of pallor and had a spheroidal shape
rather than a biconcave shape (Fig. 1b). After splenectomy,
the percentage of abnormal RBCs was not reduced com-
pared to the pre-splenectomy patients. The sizes of the
abnormal RBCs were variable, and the central zone of
pallor were still lacking in these cells (Fig. 1c).
AFM Morphological Parameters of RBCs in HS
Patients before and after Splenectomy
In healthy individuals, normal erythrocytes were biconcave
shaped (Figs. 2a and 2c), characterized by the well-
organized nanoscale lattice corresponding to the under-
lying protein network. This network can be seen in high
resolution AFM images (Fig. 2d).
Three months after the patients underwent the surgeries,
the RBCs were examined again by AFM. The sizes of the
cells increased, but they were still in spheroid shaped. In
addition, the cells surface nanostructures were still abnor-
mal, which indicated the defects of membrane proteins had
no improvement (Fig. 3).
Fig. 2 Representative AFM surface topographic images of ery-
throcytes from one healthy individual and one HS patient before and
after splenectomy. a Single erythrocytes. b Height proﬁle of the
corresponding line in a. c 3D mode of single erythrocytes from a. d
Surface ultrastructure on corresponding cells in images a. Scanning
area: 10 μm × 10 μm in a, b, and c; 1 μm × 1 μm in d
Fig. 3 Comparison of erythrocyte morphological parameters. Peak:
the maximum value of the z coordinate on the surface in the analyzed
area; Vall: the minimum value of the z coordinate on the surface in the
analyzed area; Rp-v: the difference between the peak and Vall; Ra:
the average surface roughness of the erythrocyte. * p values< 0.05;
** p values< 0.01
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Discussion
In this study, the nanostructure of abnormal RBCs from HS
patients before and after splenectomy was studied with
AFM. To validate the feasibility of using AFM to char-
acterize RBCs, we ﬁrst examined normal RBCs from
healthy subjects and noted cells with a biconcave shape and
regular cell surface lattice. This is consistent with the lit-
erature [26].
HS is characterized by a loss of membrane surface area
leading to a reduced deformability due to defects in the
membrane proteins ankyrin, band 3, β-spectrin, α-spectrin,
and protein 4.2 [1]. Low magniﬁcation AFM images
showed that the morphology of RBCs from HS patients
were spheroid with no biconcave shape just like normal
RBCs. The morphological AFM parameters were shown in
Table 2 and the analysis showed the abnormal RBCs from
HS patients had a signiﬁcantly increased “Peak value” and
signiﬁcantly decreased “valley value” vs. normal RBCs. In
addition, the abnormal RBCs had a signiﬁcantly decreased
Rp-v value vs. normal cells. This indicated that the mem-
branes of RBCs from HS patients were ﬂatter than that of
the normal RBCs.
The surface roughness (Ra) of the RBC plasma mem-
brane is an important parameter reﬂecting the changes to the
cell membrane skeleton [27]. We observed a signiﬁcantly
deceased Ra in the abnormal RBCs from HS patients vs.
normal RBCs from healthy controls (215.67 ± 6.11 nm vs.
287.00 ± 44.03 nm, P= 0.025). Since Ra represented for
the cell membrane skeleton, it indicated great differences
from the RBC from HS patients and healthy individual
since their Ra were statistically different, which led us to
believe abnormalities in the cytoskeletal proteins in the HS
cells [2, 3].
The RBCs were still spheroid in the HS patients even
they underwent splenectomy. As shown in Table 2, despite
the length of the RBCs increased vs. the pre-splenectomy
samples, they were still smaller than normal RBCs. After
splenectomy, the width of the RBCs only increased slightly.
The RBCs from HS remained smaller than the normal
RBCs. Furthermore, AFM topological analysis of the
plasma membrane of RBCs indicated that the H and h of
abnormal RBCs, which were 2236.33 ± 15.63 nm and
1098.67 ± 131.03 nm, respectively, were even higher than
that measured pre-splenectomy (H= 1644.33 ± 34.93 nm,
P< 0.001; and h= 586.33 ± 120.50 nm, P = 0.004). Our
measurements about the pre-splenectomy, RBCs were
consistent with the literature [28, 29]. The post-splenectomy
measurements suggested that splenectomy had little effect
on the defects of RBCs membrane proteins and cytoskele-
ton. Indeed, the abnormalities in the membrane ultra-
structure were even more obvious.
Our AFM observations showed that although the size of
RBCs increased after splenectomy, the abnormal RBCs
were still spheroid. Further analysis of the plasma mem-
brane ultrastructure indicated that splenectomy did not
improve the defects in the protein and cytoskeleton of the
RBC membrane. Furthermore, the size of the cell surface
particles in abnormal RBCs was smaller than that of the
normal RBCs. Our observations demonstrated that sple-
nectomy does not improve the underlying genetic defects in
the RBC plasma membrane. In fact, after splenectomy the
underlying structural abnormalities in the RBCs of HS
patients is even more obvious, as suggested by signiﬁcantly
decreased cells membrane roughness and smaller cell sur-
face particles size (Fig. 2d).
Conclusion
To the best of our knowledge, this is the ﬁrst study inves-
tigating RBCs splenectomy changes in HS patients via
AFM. In contrast to light microscopy that can only detect
changes in RBC shapes and sizes, AFM offers structural
details on the cell surface membranes, membrane proteins,
and membrane nanostructures. While splenectomy mark-
edly minimized the hemolytic anemia and other symptoms
of HS, it didn’t reduce the abnormal cells in HS patients.
And in some cases, it might even increase the number of
abnormal cells because these cells loose a place to be
destroyed. The underlying genetic defects can only be cured
by gene therapy or allogeneic hematopoietic stem cell
transplantation, while splenectomy can only relieve the
symptoms of the patients. RBCs morphology we observed
Table 2 The morphological AFM parameters of the three HS patients before and after splenectomy
L (μm) W (μm) H (nm) h (nm) Rp-v(nm) Ra(nm)
Pre-SE 5.92± 0.27** 5.81± 0.12** 1644.33± 34.93* 586.33± 120.50** 1058.00± 155.09* 215.67± 6.11*
Post-SE 6.12± 0.15* 5.85± 0.21* 2236.33± 15.63** 1098.67± 131.03** 1644.33± 34.93** 197.67± 36.20
Control 6.51± 0.27 6.22± 0.15 1358.33± 81.35 52.33± 15.04 1272.50± 48.79 287.00± 44.03
L length of the red blood cell, W width of the red blood cell, H maximum height of the cell, h the minimum height of the cell, Rp-v the valley to
peak distance, Ra the average cell surface roughness, Pre-SE pre-splenectomy, Post-SE post-splenectomy
* P< 0.05 compared to the control group; ** P< 0.01 compared to the control group
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via AFM may provide additional information to
aid HS diagnosis. Furthermore, AFM is a potential tool to
investigate the pathophysiological mechanisms of HS and
to monitor the treatment efﬁcacy in HS patients. While
AFM is limited by throughput, the relative SDs we
observed here are generally <10 % and are consistent with
that from ﬂow cytometry. Future work will expand to
higher cell counts to better understand the distribution in
RBC morphology. Superior to ﬂow cytometry and light
microscopy, AFM can provide us more information the
effects of novel treatment such as stem cell transplantation
and it has higher value in the time of stem cell
transplantation.
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